Novartis reported 8.63B in Trade Debtors for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Alcon AG ALC:SW 1.73B 19M
Amgen AMGN:US $ 4765M 286M
AstraZeneca AZN:LN 8.85B 2.01B
Bayer BAYN:GR 13.05B 2.74B
Biogen BIIB:US $ 2123M 12.8M
Bristol Myers Squibb BMY:US $ 9245M 2030M
Eli Lilly And LLY:US $ 7025M 122.2M
Fresenius FRE:GR € 7553M 56M
Galapagos GLPG:NA 126.8M 13.2M
Genmab GEN:DC 3.21B 782M
Gilead Sciences GILD:US $ 4566M 417M
GlaxoSmithKline GSK:LN 8.28B 777M
GRIFOLS GRF:SM € 644.7M 148.92M
H. Lundbeck A/S LUN:DC 3.87B 14M
Hikma Pharmaceutical HIK:LN 780M 46M
Merck MRK:GR € 4207M 83M
Novartis NOVN:VX 8.63B 22M
Novartis NVS:US $ 8632M 22M
Orion ORNBV:FH 173.8M 10.4M
Recordati REC:IM 345.65M 11.61M
Regeneron Pharmaceuticals REGN:US $ 5452M 1546.6M